Kidney Week Educational Symposia-Idiopathic Nephrotic Syndrome: Getting Less Idiopathic?

Video Transcription

Video Summary

<strong style="box-sizing: border-box; font-weight: bold; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;">Moderator(s):</strong><span style="color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff; float: none; display: inline;"> Nicola Tomas</span><br style="box-sizing: border-box; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;" /><br style="box-sizing: border-box; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;" /><strong style="box-sizing: border-box; font-weight: bold; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;">Presentation(s):</strong><br style="box-sizing: border-box; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;" />
<ul style="box-sizing: border-box; margin-top: 0px; margin-bottom: 10px; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;">
<li style="box-sizing: border-box;"><strong style="box-sizing: border-box; font-weight: bold;">Introduction</strong> - Nicola Tomas</li>
<li style="box-sizing: border-box;"><strong style="box-sizing: border-box; font-weight: bold;">Towards a Precision-Based Approach to the Treatment of INS</strong> - Kirk Campbell</li>
<li style="box-sizing: border-box;"><strong style="box-sizing: border-box; font-weight: bold;">From Bench to Bedside: How We Are Improving Our Understanding of the Pathogenesis of INS</strong> - Matthias Kretzler</li>
</ul>
<em style="box-sizing: border-box; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;">Support is provided by an educational grant from Genentech, a member of the Roche Group.</em>&nbsp;

Asset Subtitle

Moderator(s): Nicola Tomas

Presentation(s):

Introduction - Nicola Tomas
From Bench to Bedside: How We Are Improving Our Understanding of the Pathogenesis of INS - Kirk Campbell
Towards a Precision-Based Approach to the Treatment of INS - Matthias Kretzler

Support is provided by an educational grant from Genentech, a member of the Roche Group.

Meta Tag

Pathway(s) Glomerular Diseases

Pathway(s) Pediatric Nephrology

Session Type ES - Educational Symposium

Speaker(s) Nicola Tomas

Speaker(s) Matthias Kretzler

Speaker(s) Kirk Campbell

Keywords

idiopathic nephrotic syndrome

podocytopathies

minimal change disease

focal segmental glomerulosclerosis

anti-nephrin antibodies

B-cell-targeting therapy

genetic testing

APOL1

NEPTUNE MATCH

precision medicine

moderator

Nicola Tomas

INS

treatment

pathogenesis

Kirk Campbell

Matthias Kretzler

bench to bedside

Genentech